However, no significant differences were found in the total numbers of tumor-infiltrating CD45+ cells, DCs, or CD8+ T cells between tumor-bearing mice pretreated with sTGF-βR and tumor-bearing mice pretreated with IgG2a (Figure 5B). The gene discussed is PTPRC; the disease is neoplasm.